Literature DB >> 6295420

Platelet reactivity and its dependence on alpha-adrenergic receptor function in patients with ischaemic heart disease.

M Yokoyama, S Kawashima, S Sakamoto, H Akita, T Okada, T Mizutani, H Fukuzaki.   

Abstract

We studied 57 patients admitted to hospital with ischaemic heart disease, including nine patients with variant angina, to evaluate platelet reactivity and its dependence on alpha-adrenergic receptor function. The threshold concentration for biphasic platelet aggregation in response to adrenaline and adenosine diphosphate was measured in fresh platelet rich plasma. There were age related alterations in platelet responsiveness to adrenaline. In 27 age matched control subjects platelets showed adrenaline induced aggregation at a concentration higher than 0.1 mumol. The threshold concentrations for adrenaline and adenosine diphosphate were 0.91 mumol and 4.68 mumol. In 16 patients with acute infarction, 14 with old infarction, nine with effort angina, and nine with rest angina, mean values of platelet aggregation threshold for both adrenaline and adenosine diphosphate were not altered significantly when compared with control subjects. In contrast, the values for adrenaline and adenosine diphosphate in nine patients with variant angina were 0.012 mumol and 2.24 mumol and seven of them showed obvious platelet hyperactivity to adrenaline at a concentration lower than 0.1 mumol. The threshold concentration for adrenaline induced aggregation did not correlate with serum cholesterol and triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295420      PMCID: PMC485204          DOI: 10.1136/hrt.49.1.20

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  22 in total

1.  Sex and age differences in human platelet aggregation.

Authors:  M Johnson; E Ramey; P W Ramwell
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

2.  Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.

Authors:  W H Frishman; B Weksler; J P Christodoulou; C Smithen; T Killip
Journal:  Circulation       Date:  1974-11       Impact factor: 29.690

3.  Platelet function in hyperlipoproteinemia.

Authors:  A C Carvalho; R W Colman; R S Lees
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

4.  Platelet function studies in coronary artery disease.

Authors:  P P Steele; H S Weily; H Davies; E Genton
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

5.  Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina.

Authors:  H Yasue; M Touyama; M Shimamoto; H Kato; S Tanaka
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

6.  Platelet abnormalities in ischemic heart disease.

Authors:  N Salky; M Dugdale
Journal:  Am J Cardiol       Date:  1973-10       Impact factor: 2.778

7.  Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography.

Authors:  P B Oliva; D E Potts; R G Pluss
Journal:  N Engl J Med       Date:  1973-04-12       Impact factor: 91.245

8.  Platelet studies in patients with coronary artery disease and in their relatives.

Authors:  J R Hampton; R Gorlin
Journal:  Br Heart J       Date:  1972-05

9.  Platelet hypersensitivity induced by cholesterol incorporation.

Authors:  S J Shattil; R Anaya-Galindo; J Bennett; R W Colman; R A Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

10.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

View more
  1 in total

1.  Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP.

Authors:  Laura Perez-Campos-Mayoral; Eduardo Pérez-Campos; Edgar Zenteno; Abraham Majluf-Cruz; Eduardo Perez-Ortega; Diana Matias-Pérez; Francisco J Rodal-Canales; Ruth Martínez-Cruz; Socorro Pina-Canseco; Miguel Angel Reyes Franco; Gabriel Mayoral Andrade; Pedro Hernández; Belem Gallegos
Journal:  Diabetol Metab Syndr       Date:  2014-08-29       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.